Low sex drive in perimenopause: what is going on and what helps

A drop in sexual desire during perimenopause is common and usually has several causes at once: shifting hormones, hot flashes and poor sleep, pain with sex, mood changes, medications, stress, and relationship factors. It needs treatment only if it bothers you. When it does, the best results come from fixing the contributors first, then adding sex therapy and, for some women, medication.

Low desire versus a desire disorder

Desire naturally varies over a lifetime, and many women notice less spontaneous interest in sex in their 40s without being troubled by it. Clinicians draw the line at distress. Hypoactive sexual desire disorder (HSDD) means persistently low desire that causes you marked distress or strains your relationship, and is not better explained by another condition, a medication, or relationship problems alone. The International Society for the Study of Women’s Sexual Health estimates HSDD affects about 10% of adult women.

The gap between “less desire” and “distressing low desire” is large. In the PRESIDE survey of 31,581 US women, 43.1% reported some sexual problem, but only 12.0% had a problem that also caused significant distress.

How common it is at midlife

Distressing sexual problems are most common in the perimenopause years. In the same survey, they affected 14.8% of women aged 45 to 64, compared with 10.8% of younger women and 8.9% of older women. Distressing sexual problems were linked with depression, anxiety, thyroid conditions, urinary incontinence, and poor self-rated health.

What is going on in perimenopause

The Study of Women’s Health Across the Nation (SWAN) followed 3,302 women from their 40s. By late perimenopause, desire had declined and pain during sex had become more common, even after adjusting for age and health. But the menopause transition was not independently linked to arousal, satisfaction with a partner, or physical pleasure, and general health, psychological well-being, and the importance of sex mattered for every outcome.

In practice, several factors tend to stack up:

• Pain or dryness with sex. Anticipating pain dampens desire. See painful sex in perimenopause.
• Hot flashes, night sweats, and broken sleep. Fatigue makes it hard to feel interested in sex.
• Mood. Depression and anxiety are closely tied to low desire, and some antidepressants can lower it further. See perimenopausal depression.
• Hormones. Estrogen loss affects vaginal tissue and arousal; testosterone levels fall gradually through the reproductive years. No testosterone level reliably separates women with and without low desire.
• Life and relationships. Stress, caregiving, body image, conflict, and a partner’s own sexual health all play a role.
• Other conditions and medications, including thyroid disease and bladder leaks.

What helps

The ISSWSH process of care starts with education and changing what can be changed, then adds sex therapy, brain-acting medication, or hormones as needed.

Option	Who it is for	What to expect	Main cautions
Treat contributors (pain, sleep, hot flashes, mood)	Everyone	Can improve desire without a libido-specific drug	Needs a full assessment
Sex therapy, CBT, mindfulness	Most women, alone or with medication	Addresses thoughts, habits, relationship patterns	Finding a trained therapist
Hormone therapy	Women with hot flashes or vaginal symptoms	Helps desire indirectly by easing symptoms	Not a libido treatment on its own
Flibanserin	Women under 65 with diagnosed HSDD	Modest benefit over placebo	Nightly dosing; alcohol interaction
Testosterone (off-label)	Postmenopausal women with diagnosed HSDD	About one extra satisfying sexual event a month in trials	No FDA-approved product for women; long-term safety unknown

Treat the contributors first. Relief of vaginal pain with lubricants, moisturizers, or vaginal estrogen; better sleep; treatment of hot flashes; and attention to depression are the first step in the ISSWSH process of care, and may be all some women need.

Sex therapy. ISSWSH lists behavior therapy, cognitive behavioral therapy, and mindfulness-based approaches as treatment for HSDD. These can be done individually or as a couple.

Hormone therapy. The Menopause Society says systemic and vaginal estrogen improve sexual problems related to genitourinary symptoms by increasing lubrication, blood flow, and sensation, but have not been shown to increase interest or arousal independent of treating menopause symptoms. If libido is a concern, transdermal estrogen may be preferred over oral.

Flibanserin. This nightly pill was first approved for premenopausal women. In December 2025 its label was updated to cover women under 65 with acquired, generalized HSDD, which includes naturally postmenopausal women. In the postmenopausal trial (447 women on flibanserin, 455 on placebo, 24 weeks), satisfying sexual events per 28 days rose by 0.9 from a baseline of 2.0, compared with 0.6 on placebo, and desire and distress scores improved modestly. Sleepiness, sedation, or fatigue occurred in 10% versus 6% on placebo. The boxed warning says to wait at least two hours after one or two drinks before the bedtime dose, to skip the dose after three or more drinks, and not to combine it with certain drugs that block its breakdown. Another HSDD drug, bremelanotide, is approved only for premenopausal women.

Testosterone. The 2019 Global Consensus Position Statement concludes that the only evidence-based use of testosterone in women is for postmenopausal women with HSDD after a full assessment. Benefits are moderate, and there is no FDA-approved product for women. Our guide to testosterone for low libido covers the details.

Safety notes

Avoid testosterone pellets, injections, or high-dose compounded products; the Global Consensus does not recommend anything that raises levels above the normal female range. With flibanserin, follow the alcohol rules in the label. Be cautious with supplements marketed for female libido, which are not held to drug standards.

When to see a clinician

• Low desire that distresses you or is affecting your relationship
• Pain, dryness, or bleeding with sex
• Low desire alongside low mood, fatigue, weight change, or other new symptoms
• A change that began after starting a new medication

How to bring it up

You can say: “My interest in sex has dropped over the past year, and it’s bothering me. Can we look at what might be causing it?” Mention sleep, hot flashes, mood, pain, and medications. Our guide to explaining perimenopause to your partner can help with the conversation at home. An OB-GYN near you is a good place to start.